IINN vs. ICAD, INO, LUCD, NTRB, BLAC, CLGN, MODD, OM, DXR, and MDAI
Should you be buying Inspira Technologies Oxy B.H.N. stock or one of its competitors? The main competitors of Inspira Technologies Oxy B.H.N. include iCAD (ICAD), Inovio Pharmaceuticals (INO), Lucid Diagnostics (LUCD), Nutriband (NTRB), Bellevue Life Sciences Acquisition (BLAC), CollPlant Biotechnologies (CLGN), Modular Medical (MODD), Outset Medical (OM), Daxor (DXR), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry.
Inspira Technologies Oxy B.H.N. vs.
Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and iCAD (NASDAQ:ICAD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation.
In the previous week, Inspira Technologies Oxy B.H.N. had 2 more articles in the media than iCAD. MarketBeat recorded 4 mentions for Inspira Technologies Oxy B.H.N. and 2 mentions for iCAD. iCAD's average media sentiment score of 0.92 beat Inspira Technologies Oxy B.H.N.'s score of 0.15 indicating that iCAD is being referred to more favorably in the news media.
Inspira Technologies Oxy B.H.N. has a net margin of 0.00% compared to iCAD's net margin of -17.81%. Inspira Technologies Oxy B.H.N.'s return on equity of 0.00% beat iCAD's return on equity.
iCAD received 225 more outperform votes than Inspira Technologies Oxy B.H.N. when rated by MarketBeat users. However, 100.00% of users gave Inspira Technologies Oxy B.H.N. an outperform vote while only 62.13% of users gave iCAD an outperform vote.
Inspira Technologies Oxy B.H.N. has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500. Comparatively, iCAD has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500.
iCAD has higher revenue and earnings than Inspira Technologies Oxy B.H.N..
12.7% of Inspira Technologies Oxy B.H.N. shares are owned by institutional investors. Comparatively, 24.6% of iCAD shares are owned by institutional investors. 29.4% of Inspira Technologies Oxy B.H.N. shares are owned by company insiders. Comparatively, 10.3% of iCAD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Inspira Technologies Oxy B.H.N. beats iCAD on 7 of the 12 factors compared between the two stocks.
Get Inspira Technologies Oxy B.H.N. News Delivered to You Automatically
Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inspira Technologies Oxy B.H.N. Competitors List
Related Companies and Tools
This page (NASDAQ:IINN) was last updated on 1/21/2025 by MarketBeat.com Staff
